2seventy bio, Inc.

NasdaqGS:TSVT Rapporto sulle azioni

Cap. di mercato: US$254.9m

2seventy bio Gestione

Gestione criteri di controllo 0/4

2seventy bio Il CEO è Chip Baird, nominato in Apr2024, e ha un mandato di meno di un anno. la retribuzione annua totale è $ 2.93M, composta da 17.7% di stipendio e 82.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.12% delle azioni della società, per un valore di $ 294.10K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 0.6 anni e 1.2 anni.

Informazioni chiave

Chip Baird

Amministratore delegato

US$2.9m

Compenso totale

Percentuale dello stipendio del CEO17.7%
Mandato del CEOless than a year
Proprietà del CEO0.1%
Durata media del managementless than a year
Durata media del Consiglio di amministrazione1.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

There's No Escaping 2seventy bio, Inc.'s (NASDAQ:TSVT) Muted Revenues

Oct 03
There's No Escaping 2seventy bio, Inc.'s (NASDAQ:TSVT) Muted Revenues

2seventy bio, Inc.'s (NASDAQ:TSVT) Share Price Is Matching Sentiment Around Its Revenues

Jul 04
2seventy bio, Inc.'s (NASDAQ:TSVT) Share Price Is Matching Sentiment Around Its Revenues

Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term

May 11
Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term

2seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround

Apr 03

These Analysts Just Made A Massive Downgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) EPS Forecasts

Mar 07
These Analysts Just Made A Massive Downgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) EPS Forecasts

2seventy bio, Inc. (NASDAQ:TSVT) Held Back By Insufficient Growth Even After Shares Climb 49%

Feb 06
2seventy bio, Inc. (NASDAQ:TSVT) Held Back By Insufficient Growth Even After Shares Climb 49%

Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation

Jan 17
Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation

2seventy bio, Inc. (NASDAQ:TSVT) Shares Fly 44% But Investors Aren't Buying For Growth

Dec 13
2seventy bio, Inc. (NASDAQ:TSVT) Shares Fly 44% But Investors Aren't Buying For Growth

Industry Analysts Just Made A Dazzling Upgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts

May 05
Industry Analysts Just Made A Dazzling Upgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts

Industry Analysts Just Upgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts By 12%

Mar 21
Industry Analysts Just Upgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts By 12%

2seventy bio, Inc. (NASDAQ:TSVT) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Mar 19
2seventy bio, Inc. (NASDAQ:TSVT) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

Oct 04
We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

2seventy Bio: This Spinoff In The CAR-T Space Is Attractive

Sep 08

2seventy bio Prospects

Aug 23

Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook

Aug 12
Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook

2seventy bio GAAP EPS of -$2.02 misses by $0.09, revenue of $13.48M misses by $3.04M

Aug 10

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Chip Baird rispetto agli utili di 2seventy bio?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$156m

Mar 31 2024n/an/a

-US$223m

Dec 31 2023US$3mUS$518k

-US$218m

Sep 30 2023n/an/a

-US$184m

Jun 30 2023n/an/a

-US$180m

Mar 31 2023n/an/a

-US$215m

Dec 31 2022n/an/a

-US$254m

Sep 30 2022n/an/a

-US$292m

Jun 30 2022n/an/a

-US$284m

Mar 31 2022n/an/a

-US$291m

Dec 31 2021US$2mUS$491k

-US$292m

Sep 30 2021n/an/a

-US$308m

Jun 30 2021n/an/a

-US$320m

Mar 31 2021n/an/a

-US$222m

Dec 31 2020US$2mUS$475k

-US$120m

Compensazione vs Mercato: La retribuzione totale di Chip ($USD 2.93M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 1.47M ).

Compensazione vs guadagni: La retribuzione di Chip è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

Chip Baird (52 yo)

less than a year

Mandato

US$2,927,118

Compensazione

Mr. William D. Baird III, also known as Chip, serves as Chief Executive Officer, President and Director of 2seventy bio, Inc. since April 1, 2024. He was Principal Financial Officer and Principal Accountin...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
William Baird
CEO, President & Directorless than a yearUS$2.93m0.12%
$ 294.1k
Victoria Eatwell
Chief Financial Officerless than a yearNessun dato0.66%
$ 1.7m
Jessica Snow
Senior VP of Quality and Head of Operationsless than a yearNessun dato0.30%
$ 771.0k
Anna Truppel-Hartmann
Chief Medical Officerless than a yearNessun datoNessun dato

0.6yrs

Durata media

45yo

Età media

Gestione esperta: Il team dirigenziale di TSVT non è considerato esperto (durata media 0.6 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
William Baird
CEO, President & Directorless than a yearUS$2.93m0.12%
$ 294.1k
Eli Casdin
Independent Directorless than a yearNessun datoNessun dato
Nick Leschly
Chairman of the Boardless than a yearUS$9.08m1.43%
$ 3.6m
Charles Newton
Independent Directorless than a yearNessun datoNessun dato
Marcela Maus
Independent Director3.1yrsUS$290.00k0.028%
$ 72.3k
Denice Torres
Lead Independent Director3.1yrsUS$304.00k0.038%
$ 96.6k
Sarah J. Glickman
Independent Director3.1yrsUS$303.00k0.028%
$ 72.3k
Wei Lin
Independent Director1.7yrsUS$622.05k0.019%
$ 48.2k

1.2yrs

Durata media

53yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di TSVT non è considerato esperto (durata media del mandato 1.2 anni), il che suggerisce un nuovo consiglio.